Indirect parasympathomimetic activity of metoclopramide: Reversible inhibition of cholinesterases from human central nervous system and blood

Pharmacological Research

Volumn 34, Issue 1-2, 1996, Pages 65-72

  Chemnitius, Jörg Michael ^a   Haselmeyer, Karl Heinz ^a   Gonska, Bernd Dieter ^a   Kreuzer, Heinrich ^a   Zech, Ronald ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Acetylcholinesterase; Anti emetic drugs; Cholinesterase; Inhibition kinetics; Metoclopramide; Parasympathomimetic activity; Prokinetic drugs; Reversible inhibitor

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ACETYLTHIOCHOLINE; ANTIEMETIC AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE; ERYTHROCYTE ENZYME; ISOENZYME; METOCLOPRAMIDE; PROKINETIC AGENT;

ARTICLE; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM; CHOLINERGIC ACTIVITY; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; ENZYME SUBSTRATE; ERYTHROCYTE; EXTRAPYRAMIDAL SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 0030184038     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.9999     Document Type: Article

References (46)

1. 1. Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS. Metoclopramide: A review of its pharmacological properties and clinical use. Drugs 1976; 12: 81-131.
2. 2. Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA, Heel RC. Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs 1983; 25: 451-94.
3. 3. Malagelada JR, Rees WDW, Mazzotta LJ, Go VLW. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis. Effect of metoclopramide and bethanechol. Gastroenterology 1980; 78: 286-93.
4. 4. Colls BM, Ferry DG, Gray AJ, Harvey VJ, McQueen EG. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy. New Zealand Med J 1980; 91: 449-51.
5. 5. Singh MS, Lean TH. The use of metoclopramide (Maxlon) in hyperemesis gravidarum. Proc Obstet Gynaecol Soc Singapore 1970; 1: 43-7.
6. 6. Kebabian JW, Calne DB. Multiple receptors for dopamine. Nature 1979; 227: 93-6.
7. 7. MacDonald TM. Metoclopramide, domperidone and dopamine in man: actions and interactions. Eur J Clin Pharmacol 1991; 40: 225-30.
8. 8. Buchheit KH, Buhl T. Stimulant effects of 5-hydroxytryptamine on guinea pig stomach preparations in vitro. Eur J Pharmacol 1994; 262: 91-7.
9. 4) positively coupled to adenylate cyclase in neurons. Naunyn-Schmiedeberg's Arch Pharmacol 1989; 340: 403-11.
10. 10. Costall B, Naylor RJ. 5-Hydroxytryptamine: New receptors and novel drugs for gastrointestinal motor disorders. Scand J Gastroenterol 1990; 25: 769-87.
11. 11. Schuurkes JAJ, Helsen LFM, Ghoos E. Stimulation of gastroduodenal motor activity: Dopaminergic and cholinergic modulation. Drug Dev Res 1985; 8: 233-41.
12. 12. Fumagalli I, Hammer B. Cisapride versus metoclopramide in the treatment of functional dyspepsia. Scand J Gastroenterol 1994; 29: 33-7.
13. 13. Hay AM, Man WK. Effect of metoclopramide on guinea pig stomach. Critical dependence on intrinsic stores of acetylcholine. Gastroenterology 1979; 76: 492-8.
14. 14. Okwuasaba FK, Hamilton JT. The effect of metoclopramide on intestinal muscle responses and the peristaltic reflex in vitro. Can J Physiol Pharmacol 1976; 54: 393-404.
15. 15. Zar MA, Ebong OO, Bateman DN. Effect of metoclopramide in guinea-pig ileum longitudinal muscle: Evidence against dopamine-mediation. Gut 1982; 23: 66-70.
16. 16. Kilbinger H, Kruel R, Pfeuffer-Friederich I, Wessler I. The effects of metoclopramide on acetylcholine release and on smooth muscle response in the isolated guinea-pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 1982; 319: 231-8.
17. 17. Vacca C, Maione S, Tozzi A, Marmo E. Benzamides and cholinesterases. Res Commun Chemical Pathol Pharmacol 1987; 2: 193-201.
18. 18. Karanth KS, Rao SG, Kumari P, Guruswami MN. Anticholinesterase activity of metoclopramide. Indian J Med Res 1981; 74: 125-8.
19. 19. Kao YJ, Tellez J, Turner DR. Dose-dependent effect of metoclopramide on cholinesterases and suxamethonium metabolism. Br J Anaesthesia 1990; 65: 220-4.
20. 20. Rao SS, Kaveeshwar U, Mihra PK. Difference in the inhibition of plasma cholinesterase activity by antiemetic metoclopramide in humans and mice. Pharmazie 1992; 47: 66-7.
21. 21. Brunton LL. Agents affecting gastrointestinal water flux and motility; emesis and antiemetics; bile acids and pancreatic enzymes. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw Hill, 1996: 917-49.
22. 22. Chemnitius JM, Haselmeyer KH, Kreuzer H, Zech R. Indirect parasympathomimetic activity (IPA) of class I antiarrhythmic drugs. Pharmacol Res 1995; 31, Suppl: 73.
23. 23. Morton RK. Methods of extraction of enzymes from animal tissues. Meth Enzymol 1955; 1: 156-72.
24. 24. Chemnitius JM, Zech R. Carboxylesterases in primate brain: Characterization of multiple forms. Int J Biochem 1983; 15: 1019-25.
25. 25. Ellman GL, Cortney D, Andrews V, Featherstone FM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
26. 26. Krupka RM. Acetylcholinesterase: Triethylammonium inhibition of deacetylation. Biochemistry 1964; 3: 1749-54.
27. 27. Krupka RM. The mechanism of action of acetylcholinesterase: Substrate inhibition and the binding of inhibitors. Biochemistry 1966; 6: 1983-6.
28. 28. Dixon M, Webb EC. Enzymes. 2nd ed. London: Longman Group Ltd, 1971.
29. 3 antagonist action in the control of emesis. Pharmacol Res 1995; 31: 257-60.
30. 4 receptors and gastrointestinal prokinetic action. Pharmacol Res 1991; 24: 5-14.
31. 4 receptors and potential therapeutic implications. Drugs Fut 1991; 16: 1011-26.
32. 3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 1994; 349: 338-45.
33. 33. Cornish-Bowden A. Fundamentals of enzyme kinetics. London: Butterworth & Co Ltd, 1979.
34. 34. Turner DR, Kao YJ, Bivona C. Neuromuscular relaxation by suxamethonium following treatment with histamine type II antagonists or metoclopramide. Br J Anaesthesia 1989; 63: 348-50.
35. 35. Novak TV, Harrington B. Effect of cholinergic agonists on muscle from rodent proximal and distal small intestine. Gastroenterology 1985; 88: 1118-25.
36. 36. Morisset J, Geoffrion L, Larose L, Lanoe L, Poirier GG. Distribution of muscarinic receptors in the digestive tract organs. Pharmacology 1981; 22: 189-95.
37. 37. Sine JP, Ferrand R, Cloarec D, Lehur PA, Colas B. Human intestine epithelial cell acetyl-and butyrylcholinesterase. Mol Cell Biochem 1991; 108: 145-9.
38. 38. Sine JP, Ferrand R, Colas B. Acetylcholinesterase and butyrylcholinesterase in the gut mucosal cells of various mammalian species: Distribution along the intestine and molecular forms. Comp Biochem Physiol 1988; 91C: 597-602.
39. 39. Koelle GB. Cholinesterases of the tissues and sera of rabbits. Biochem J 1953; 53: 217-26.
40. 40. Chemnitius JM, Haselmeyer KH, Zech R. Brain cholinesterases: Differentiation of target enzymes for toxic organophosphorus compounds. Biochem Pharmacol 1983; 32: 1693-9.
41. 41. Chemnitius JM, Chemnitius GC, Haselmeyer KH, Kreuzer H, Zech R. Cholinesterases of heart muscle. Characterization of multiple enzymes using kinetics of irreversible organophosphorus inhibition. Biochem Pharmacol 1992; 43: 823-9.
42. 42. Vergin H, Bishop-Freudling GB, Strobel K, Reeves DS. Untersuchungen zur Pharmakokinetik und zur Bioäquivalenz unterschiedlicher oraler Formulierungen von Metoclopramid. Arzneim Forsch/Drug Res 1983; 33: 458-62.
43. 43. Brechot JM, Dupeyron JP, Delattre C, Chastang C, Laaban JP, Rochemaure J. Continuous infusion of high-dose metoclopramide: Comparison of pharmacokinetically adjusted and standard doses for the control of cisplatin-induced acute emesis. Eur J Clin Pharmacol 1991; 40: 283-6.
44. 44. Sanger GJ. Effects of metoclopramide and domperidone on cholinergically mediated contractions of human isolated smooth muscle. J Pharm Pharmacol 1985; 37: 661-4.
45. 45. Iwanaga Y, Kimura T, Miyashita N, Morikawa K, Nagata O, Itoh Z, Kondo Y. Characterization of acetylcholinesterase-inhibition by itopride. Jpn J Pharmacol 1994; 66: 317-22.
46. 46. Iwanaga Y, Suzuki N, Kato K, Kimura T, Morikawa K, Kato H, Ito Y, Gomi Y. Stimulatory effects of HSR-803 on ileal motor activity. Jpn J Pharmacol 1993; 62: 395-401.